中西醫(yī)結(jié)合在慢加急性肝衰竭全病程管理中的特色和優(yōu)勢
通信作者:,wangxianbo638@163.com(ORCID:0000-0002-3593-5741)
關(guān)鍵詞:慢加急性肝功能衰竭;中西醫(yī)結(jié)合療法;多學(xué)科診療
基金項目:國家自然科學(xué)基金(82474419,82474426);北京市衛(wèi)生健康委員會-研究型病房卓越臨床研究計劃(BRWEP2024W102170107);北京市醫(yī)院管理中心創(chuàng)新夢工場經(jīng)費資助(202335)
Characteristics and advantages of integrated traditional Chinese and Western medicine therapy in whole-course management of acute-on-chronic liver failure
GAO Fangyuan,F(xiàn)ENG Ying,WANG Xianbo
Center of Integrative Medicine,Beijing Ditan Hospital,Capital Medical University,Beijing 1Ooo15,China
Corresponding author:WANG Xianbo,wangxianbo638@163.com(ORCID: 0000-0002-3593-5741)
Abstract:Acute-on-chronic liverfailure(ACLF)isacomplexclinical syndrome characterized byacute deteriorationof liver functioncaused bydiferent factorson the basisof chronic liverdisease,accompanied by liver failureand/or extrahepatic organ failure,and itoften hasa high short-term mortalityrate.With the increasing evidenceof evidence-based medicine, multipleguidelinesandconsensus statements havebeenreleased,suchas Guidelines forclinicaldiagnosisandtreatmentof acute-on-chronic liver failure intraditional Chinese medicine,Expertconsensus on thediagnosisand treatmentofacute-onchronicliverfailurewithintegratedtraditionalChineseandWesternmedicine,andGuidelines fortheintegrated traditional Chineseand Westernmedicinediagnosisandtreatmentofacute-on-chronic liverfailure,and integrated traditional Chinese and Western medicine therapies for ACLF have been constantly standardizedand perfected.This article explores the characteristicsandadvantagesof integrated traditional Chinese andWestern medicine therapyin the whole-course management of ACLF from theaspectsof early warning and prevention,treatment in theacute stage,managementof complications,andrehabilitationcare,inorder to enhancetheunderstandingof traditional Chinese and Western medicine treatment strategies among clinicians.
KeyWords:Acute-On-ChonicLiverFilure;IntegratedChineseTraditionalandWesteMedicineTherapy;Multi-DisciplinaryTeam
Research funding:NationalNaturalScienceFoundationofChina(82474419,82474426);BeijingMunicipal HealthCommisionExcelent Clinical ResearchProgram for Research Wards(BRWEP2024W102170107);Beijing HospitalsAuthority Innovation Studio of Young Staff Funding Support (202335)
慢加急性肝衰竭(ACLF)具有發(fā)病急驟、進展迅速、并發(fā)癥多、病死率高等特點,中西醫(yī)結(jié)合作為我國獨特的醫(yī)療模式,在ACLF這類復(fù)雜危重癥的全病程管理中展現(xiàn)出顯著特色與優(yōu)勢。(剩余22797字)
- 中西醫(yī)結(jié)合在慢加急性肝衰竭全病...
- 慢加急性肝衰竭的證候演變及證治...
- 中醫(yī)治療肝衰竭60年:從臨床洞...
- 新技術(shù)在慢加急性肝衰竭全病程管...
- 慢加急性肝衰竭預(yù)后評分模型和標(biāo)...
- 《2025年歐洲肝病學(xué)會臨床實...
- 《2025年亞太肝病學(xué)會臨床實...
- 《2025年美國胃腸病學(xué)院臨床...
- 調(diào)整抗病毒治療方案對慢性乙型肝...
- 1267例兒童慢性乙型肝炎患者...
- 臨床醫(yī)生對《慢性乙型肝炎防治指...
- 鹽酸可洛派韋聯(lián)合索磷布韋治療基...
- 血清肌酐/胱抑素C比值與成人非...
- 基于體檢人群調(diào)查代謝相關(guān)脂肪性...
- 抑制脯氨酰內(nèi)肽酶表達對非酒精性...
- 高代謝風(fēng)險慢性乙型肝炎患者發(fā)生...
- 超聲內(nèi)鏡下選擇性食管胃靜脈曲張...
- 經(jīng)頸靜脈肝內(nèi)門體分流術(shù)治療肝硬...
- 靶向葉酸受體 α(FRα) 的...
- 基于肌少癥的慢加急性肝衰竭患者...
- 細(xì)菌性肝膿腫并發(fā)膿毒癥的危險因...
- 肝豆?fàn)詈俗冃訩-F環(huán)分級與認(rèn)知...
- 機器人胰腺實質(zhì)保留手術(shù)與腹腔鏡...
- 表觀遺傳學(xué)在瘦型非酒精性脂肪性...
- 脂肪量和肥胖相關(guān)基因在代謝相關(guān)...
- 衰老驅(qū)動代謝相關(guān)脂肪性肝病的機...
- 原發(fā)性膽汁性膽管炎合并干燥綜合...
- 胰島素樣生長因子-I(IGF-...
- 液體活檢在肝細(xì)胞癌診斷及治療中...
- 中藥調(diào)控腫瘤相關(guān)巨噬細(xì)胞對肝細(xì)...
- 代謝組學(xué)在中醫(yī)藥防治肝衰竭中的...
- 免疫分子及相關(guān)免疫細(xì)胞在肝衰竭...
- 基因修飾間充質(zhì)干細(xì)胞在肝臟疾病...
- 轉(zhuǎn)運RNA衍生小RNA(tsR...
- 吲哚菁綠熒光顯像技術(shù)在膽道閉鎖...
- Gut丨里程碑式突破!水稻“種...
- Gut|NLRP6缺失通過E-...
- HepatologyResea...
- HepatologyResea...
- JournalofGastro...
- 《臨床肝膽病雜志》對形態(tài)學(xué)圖片...
- 《臨床肝膽病雜志》論著類文章摘...
- 《臨床肝膽病雜志》2025年1...
- 《臨床肝膽病雜志》入展第三十一...
- 《臨床肝膽病雜志》被美國BIO...